494 related articles for article (PubMed ID: 18703852)
1. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid.
Ito Y; Miyauchi A
Endocr J; 2009; 56(2):177-92. PubMed ID: 18703852
[TBL] [Abstract][Full Text] [Related]
2. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.
Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA
Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018
[TBL] [Abstract][Full Text] [Related]
3. Cystic lymph node metastasis in papillary thyroid carcinoma.
Miseikyte-Kaubriene E; Trakymas M; Ulys A
Medicina (Kaunas); 2008; 44(6):455-9. PubMed ID: 18660640
[TBL] [Abstract][Full Text] [Related]
4. Management of differentiated thyroid cancer of the follicular epithelium.
Pacini F
Ann Med; 2012 Nov; 44(7):651-5. PubMed ID: 21668295
[TBL] [Abstract][Full Text] [Related]
5. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
[TBL] [Abstract][Full Text] [Related]
7. [Differentiated thyroid gland carcinoma in children and adolescents].
Meller J; Conrad M; Behr T; Gratz S; Becker W
Klin Padiatr; 1998; 210(5):373-8. PubMed ID: 9782484
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cancers. I. Papillary, follicular, and Hürthle cell.
Goldman ND; Coniglio JU; Falk SA
Otolaryngol Clin North Am; 1996 Aug; 29(4):593-609. PubMed ID: 8844732
[TBL] [Abstract][Full Text] [Related]
9. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
10. Advances in the diagnosis and management of well-differentiated thyroid cancers.
Weigel RJ
Curr Opin Oncol; 1996 Jan; 8(1):37-43. PubMed ID: 8868098
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentations and treatment for 74 occult thyroid carcinoma. Comparison with nonoccult thyroid carcinoma in Taiwan.
Lin JD; Chao TC; Weng HF; Huang HS; Ho YS
Am J Clin Oncol; 1996 Oct; 19(5):504-8. PubMed ID: 8823480
[TBL] [Abstract][Full Text] [Related]
12. Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy.
Ippolito A; Vella V; La Rosa GL; Pellegriti G; Vigneri R; Belfiore A
Thyroid; 2001 Aug; 11(8):783-7. PubMed ID: 11525273
[TBL] [Abstract][Full Text] [Related]
13. Treatment of locally aggressive well-differentiated thyroid cancer.
Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
[TBL] [Abstract][Full Text] [Related]
14. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
15. Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.
Lin JD; Hsueh C; Chao TC
Thyroid; 2009 Oct; 19(10):1053-9. PubMed ID: 19772423
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategy for low-risk thyroid cancer in Kanaji Thyroid Hospital.
Kammori M; Fukumori T; Sugishita Y; Hoshi M; Yamada T
Endocr J; 2014; 61(1):1-12. PubMed ID: 24067543
[TBL] [Abstract][Full Text] [Related]
17. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
[TBL] [Abstract][Full Text] [Related]
18. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
[TBL] [Abstract][Full Text] [Related]
20. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
